Concepts (141)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Interferon Type I | 4 | 2014 | 206 | 0.980 |
Why?
|
| Multiple Sclerosis | 5 | 2014 | 263 | 0.970 |
Why?
|
| Human T-lymphotropic virus 1 | 3 | 2009 | 11 | 0.570 |
Why?
|
| Interferon-alpha | 3 | 2008 | 215 | 0.510 |
Why?
|
| Interferon-beta | 4 | 2012 | 126 | 0.500 |
Why?
|
| Herpesviridae | 1 | 2014 | 14 | 0.440 |
Why?
|
| Herpesviridae Infections | 1 | 2014 | 46 | 0.430 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2012 | 212 | 0.400 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 2013 | 235 | 0.380 |
Why?
|
| Neuromyelitis Optica | 1 | 2011 | 24 | 0.350 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 1 | 2011 | 65 | 0.340 |
Why?
|
| Immunologic Factors | 1 | 2012 | 179 | 0.340 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2012 | 395 | 0.290 |
Why?
|
| Immunotherapy | 1 | 2014 | 763 | 0.280 |
Why?
|
| Dependovirus | 1 | 2004 | 37 | 0.210 |
Why?
|
| Gene Products, gag | 1 | 2003 | 12 | 0.210 |
Why?
|
| Virus Assembly | 1 | 2003 | 22 | 0.210 |
Why?
|
| Membrane Microdomains | 1 | 2003 | 54 | 0.200 |
Why?
|
| Gene Expression Regulation | 2 | 2002 | 2059 | 0.200 |
Why?
|
| Astrocytes | 1 | 2004 | 151 | 0.200 |
Why?
|
| Apolipoproteins E | 1 | 2004 | 136 | 0.200 |
Why?
|
| Genetic Vectors | 1 | 2004 | 446 | 0.190 |
Why?
|
| Interleukin-10 | 2 | 2004 | 166 | 0.180 |
Why?
|
| GTP-Binding Proteins | 1 | 2002 | 148 | 0.180 |
Why?
|
| Interferons | 1 | 2002 | 130 | 0.180 |
Why?
|
| Antiviral Agents | 2 | 2009 | 504 | 0.170 |
Why?
|
| Phosphoproteins | 1 | 2002 | 263 | 0.170 |
Why?
|
| Monocytes | 1 | 2002 | 231 | 0.170 |
Why?
|
| Herpesvirus 1, Equid | 2 | 1997 | 2 | 0.160 |
Why?
|
| Trans-Activators | 1 | 2002 | 447 | 0.160 |
Why?
|
| Repressor Proteins | 1 | 2002 | 447 | 0.150 |
Why?
|
| Alzheimer Disease | 1 | 2004 | 606 | 0.150 |
Why?
|
| Lymphocyte Activation | 1 | 2002 | 810 | 0.150 |
Why?
|
| Interferon Regulatory Factor-1 | 2 | 2012 | 19 | 0.140 |
Why?
|
| Viral Proteins | 2 | 1997 | 289 | 0.140 |
Why?
|
| STAT1 Transcription Factor | 2 | 2012 | 58 | 0.140 |
Why?
|
| Signal Transduction | 2 | 2012 | 3586 | 0.130 |
Why?
|
| DNA-Binding Proteins | 2 | 2002 | 1268 | 0.130 |
Why?
|
| Cell Line | 4 | 2008 | 2533 | 0.120 |
Why?
|
| T-Lymphocytes | 1 | 2002 | 1316 | 0.110 |
Why?
|
| Up-Regulation | 2 | 2011 | 741 | 0.110 |
Why?
|
| Transcription Factors | 1 | 2002 | 1730 | 0.110 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2012 | 380 | 0.100 |
Why?
|
| Interferon Regulatory Factors | 1 | 2013 | 77 | 0.100 |
Why?
|
| Jurkat Cells | 1 | 2012 | 83 | 0.100 |
Why?
|
| Humans | 12 | 2014 | 96127 | 0.080 |
Why?
|
| Virion | 2 | 2003 | 62 | 0.080 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 1 | 2009 | 16 | 0.080 |
Why?
|
| Virus Activation | 1 | 2009 | 43 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2012 | 1973 | 0.070 |
Why?
|
| TYK2 Kinase | 1 | 2008 | 7 | 0.070 |
Why?
|
| STAT2 Transcription Factor | 1 | 2008 | 7 | 0.070 |
Why?
|
| Luciferases | 1 | 2008 | 130 | 0.070 |
Why?
|
| Adult | 5 | 2012 | 28718 | 0.070 |
Why?
|
| Genes, Reporter | 1 | 2008 | 281 | 0.070 |
Why?
|
| RNA, Messenger | 3 | 2002 | 2092 | 0.070 |
Why?
|
| Gene Expression | 2 | 2004 | 1322 | 0.060 |
Why?
|
| Middle Aged | 4 | 2012 | 28363 | 0.060 |
Why?
|
| Risk Assessment | 1 | 2014 | 2480 | 0.060 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2008 | 303 | 0.060 |
Why?
|
| Time Factors | 2 | 2012 | 5585 | 0.060 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2013 | 2494 | 0.060 |
Why?
|
| Biomarkers | 1 | 2011 | 1933 | 0.060 |
Why?
|
| Animals | 5 | 2014 | 28945 | 0.050 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2004 | 59 | 0.050 |
Why?
|
| Receptors, Interferon | 1 | 2004 | 34 | 0.050 |
Why?
|
| Theilovirus | 1 | 2003 | 15 | 0.050 |
Why?
|
| Cardiovirus Infections | 1 | 2003 | 25 | 0.050 |
Why?
|
| Lymphotoxin-alpha | 1 | 2003 | 43 | 0.050 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2003 | 90 | 0.050 |
Why?
|
| Central Nervous System | 1 | 2004 | 154 | 0.050 |
Why?
|
| Male | 4 | 2012 | 45870 | 0.050 |
Why?
|
| Female | 5 | 2012 | 50063 | 0.050 |
Why?
|
| Interferon Regulatory Factor-2 | 1 | 2002 | 4 | 0.050 |
Why?
|
| 2',5'-Oligoadenylate Synthetase | 1 | 2002 | 9 | 0.050 |
Why?
|
| Myxovirus Resistance Proteins | 1 | 2002 | 8 | 0.050 |
Why?
|
| Interferon beta-1a | 1 | 2002 | 18 | 0.050 |
Why?
|
| Interferon beta-1b | 1 | 2002 | 39 | 0.050 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2004 | 564 | 0.050 |
Why?
|
| Tyrosine | 1 | 2002 | 132 | 0.050 |
Why?
|
| RNA, Viral | 2 | 2009 | 311 | 0.050 |
Why?
|
| Serine | 1 | 2002 | 108 | 0.050 |
Why?
|
| Antigens, Viral | 2 | 2003 | 135 | 0.040 |
Why?
|
| Kinetics | 1 | 2004 | 1562 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2002 | 527 | 0.040 |
Why?
|
| Models, Biological | 1 | 2008 | 1815 | 0.040 |
Why?
|
| Alleles | 1 | 2004 | 1157 | 0.040 |
Why?
|
| Hippocampus | 1 | 2004 | 459 | 0.040 |
Why?
|
| Electrophoresis | 1 | 1999 | 54 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2002 | 1034 | 0.040 |
Why?
|
| DNA Probes | 1 | 1999 | 77 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2004 | 3490 | 0.040 |
Why?
|
| Phosphorylation | 1 | 2002 | 1157 | 0.040 |
Why?
|
| Cricetinae | 2 | 1997 | 544 | 0.040 |
Why?
|
| Staphylococcus aureus | 1 | 2002 | 287 | 0.040 |
Why?
|
| Herpes Simplex Virus Protein Vmw65 | 1 | 1997 | 5 | 0.030 |
Why?
|
| Proteins | 1 | 2002 | 816 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2002 | 2943 | 0.030 |
Why?
|
| Vero Cells | 1 | 1996 | 106 | 0.030 |
Why?
|
| Ribonucleases | 1 | 1996 | 97 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1996 | 422 | 0.030 |
Why?
|
| Rabbits | 1 | 1996 | 639 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 1996 | 2092 | 0.020 |
Why?
|
| Mice | 2 | 2004 | 12562 | 0.020 |
Why?
|
| DNA | 2 | 2013 | 1332 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 1996 | 3041 | 0.020 |
Why?
|
| Autoantibodies | 1 | 2013 | 281 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2013 | 1958 | 0.020 |
Why?
|
| DNA-Directed RNA Polymerases | 1 | 2009 | 106 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2009 | 1195 | 0.020 |
Why?
|
| Disease Progression | 1 | 2009 | 1568 | 0.010 |
Why?
|
| Lymphocyte Count | 1 | 2004 | 102 | 0.010 |
Why?
|
| Lymphotoxin-beta | 1 | 2003 | 6 | 0.010 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2003 | 19 | 0.010 |
Why?
|
| Lymphotoxin beta Receptor | 1 | 2003 | 28 | 0.010 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2003 | 43 | 0.010 |
Why?
|
| Demyelinating Diseases | 1 | 2003 | 51 | 0.010 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2004 | 151 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 2004 | 467 | 0.010 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2003 | 320 | 0.010 |
Why?
|
| Lymphocytes | 1 | 2004 | 489 | 0.010 |
Why?
|
| Spinal Cord | 1 | 2003 | 252 | 0.010 |
Why?
|
| Killer Cells, Natural | 1 | 2003 | 294 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2003 | 482 | 0.010 |
Why?
|
| Antibodies, Viral | 1 | 2003 | 348 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2004 | 1175 | 0.010 |
Why?
|
| Phosphorus Radioisotopes | 1 | 1999 | 21 | 0.010 |
Why?
|
| Acrylic Resins | 1 | 1999 | 23 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2003 | 713 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 1999 | 179 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2003 | 1829 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2003 | 2163 | 0.010 |
Why?
|
| Artifacts | 1 | 1999 | 252 | 0.010 |
Why?
|
| Apoptosis | 1 | 2004 | 1763 | 0.010 |
Why?
|
| Horses | 1 | 1997 | 36 | 0.010 |
Why?
|
| Open Reading Frames | 1 | 1997 | 124 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2003 | 1276 | 0.010 |
Why?
|
| Protein Binding | 1 | 1999 | 1561 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2009 | 9173 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 1999 | 2040 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 1999 | 2883 | 0.010 |
Why?
|